AtheroTalk
- Episodios
- 42
- Se publica
- cada dos semanas
- Último episodio
- 10 Nov 2026
Sobre el podcast
AtheroTalk is your go-to podcast for in-depth discussions on atherosclerosis and cardiovascular health. Join leading experts as they explore the latest research, breakthrough treatments, and real-world insights into preventing and managing heart disease. Whether you're a healthcare professional, researcher, or just passionate about heart health, AtheroTalk delivers valuable knowledge and practical tips straight from the experts. Tune in to stay informed and inspired about the future of cardiovascular care! -------------------------- This podcast is proudly initiated by the EAS Young Fellows.
Episodios 42
E42: Konstantinos Koskinas
In this engaging conversation, we explore the future of cardiovascular prevention from the persistent gaps in dyslipidaemia management and the growing cardiovascular impact of obesity to the emerging role of …
Notas del episodio
In this engaging conversation, we explore the future of cardiovascular prevention from the persistent gaps in dyslipidaemia management and the growing cardiovascular impact of obesity to the emerging role of GLP-1 receptor agonists and new approaches to reducing cardiovascular risk. Prof. Konstantinos Koskinas also shares insights from his work in coronary disease and intracoronary imaging, reflects on lessons learned throughout his career, and offers valuable advice to the next generation of cardiologists.
---------------------------------------------------
Script-prep: Tatyana Storozhenko
Interviewer: Svetlana Stoica
E41: Nabil Seidah & Marianne Abi Fadel
In this episode of AtheroTalk, we meet two pioneers of the PCSK9 story, Prof. Nabil Seidah and Prof. Marianne Abi Fadel. They take us through the discoveries that transformed our understanding of PCSK9 and …
Notas del episodio
In this episode of AtheroTalk, we meet two pioneers of the PCSK9 story, Prof. Nabil Seidah and Prof. Marianne Abi Fadel. They take us through the discoveries that transformed our understanding of PCSK9 and familial hypercholesterolaemia - from genetic discovery and basic science to therapies that have changed cardiovascular care - while sharing personal reflections on collaboration and the future of lipidology.
---------------------------------------------------
Script-prep: Fotios Barkas, Azin Kheirkhah
Interviewer: Fotios Barkas, Azin Kheirkhah
E40: Patrick Rensen
In this episode of AtheroTalk, we are delighted to host Prof. Patrick C. N. Rensen from Leiden University Medical Center, Professor of Endocrinology and a leading researcher in cardiometabolic science. His work …
Notas del episodio
In this episode of AtheroTalk, we are delighted to host Prof. Patrick C. N. Rensen from Leiden University Medical Center, Professor of Endocrinology and a leading researcher in cardiometabolic science. His work focuses on inter-organ crosstalk in glucose and lipid metabolism and its implications for cardiovascular and metabolic disease.
By listening to Prof. Rensen’s scientific journey and translational perspective, we explore how experimental models can help us better understand cardiometabolic disease, from the APOE*3-Leiden.CETP mouse model to emerging heart-on-chip technologies. We also discuss the fascinating role of brown adipose tissue in human cardiometabolic health, strategies to enhance its function, and some of the common misconceptions surrounding it.
The conversation further takes us into the interplay between circadian rhythms and metabolism, as well as the translational potential of ongoing clinical studies such as CoolBAT and TikTac. Beyond science, Prof. Rensen also shares his perspective on teaching, scientific communication, and the lessons that can be learned from ideas and projects that do not always go as planned.
—————————————————
Script-prep: Hana Bartuskova
Interviewer: Yusuf Ziya Sener
E39: Katariina Öörni
Prof. Katariina Öörni, Co-Editor of Atherosclerosis, the official journal of the EAS and a member of the EAS Executive Committee for Communication in 2025-2028, is our distinguished guest in this episode of …
Notas del episodio
Prof. Katariina Öörni, Co-Editor of Atherosclerosis, the official journal of the EAS and a member of the EAS Executive Committee for Communication in 2025-2028, is our distinguished guest in this episode of AtheroTalk.
The conversation paints us a vivid picture about Prof. Öörni’s academic journey and research and is full of inspiring stories. Tune in to hear more about the function of lipoprotein particles and their role in atherosclerosis development, the Atherosclerosis Research Laboratory in the Wihuri Research Institute, the Finnish lifestyle that promotes cardiovascular health, very unusual research subjects and brilliant advice for young clinicians and researchers.
---------------------------------------------------
Script-prep: Hana Bartušková
Interviewer: Laura Gaita
E38: Heribert Schunkert
In this episode of AtheroTalk we are privileged to host Prof. Heribert Schunkert, the recipient of the 2026 EAS Anitschkow Prize - the Society’s most prestigious award - for his pioneering work in the genetics …
Notas del episodio
In this episode of AtheroTalk we are privileged to host Prof. Heribert Schunkert, the recipient of the 2026 EAS Anitschkow Prize - the Society’s most prestigious award - for his pioneering work in the genetics of atherosclerosis and cardiovascular disease.
By listening to Prof. Schunkert’s inspiring academic journey and thought-provoking insights regarding the future of cardiovascular disease management, this discussion makes us wonder about how we can include polygenic risk scores in daily clinical practice, how we can improve the care of our patients with familial hypercholesterolemia and about how we can overcome the biggest challenges in cardiometabolic medicine.
---------------------------------------------------
Script-prep: Laura Gaita, Azin Kheirkhah, Tatyana Storozhenko
Interviewer: Laura Gaita
E37: Soheil Saeedi, Cesare Canepari & Berkan Kurt
How do we beat atherosclerosis? In this special EAS Stage session, we bring together three rising scientists tackling that single question from completely different angles. Dr Soheil Saeedi (University of …
Notas del episodio
How do we beat atherosclerosis? In this special EAS Stage session, we bring together three rising scientists tackling that single question from completely different angles. Dr Soheil Saeedi (University of Zurich) explores cardiovascular aging and how a gut microbial metabolite can drive endothelial senescence. Dr Cesare Canepari (San Raffaele Telethon Institute for Gene Therapy) makes the case for gene therapy and genome editing to actually cure familial hypercholesterolemia. Dr Berkan Kurt (University Hospital Aachen) brings the clinician-scientist's perspective on inflammation, hsCRP, and emerging biomarkers, straight from the bedside. Three labs, three countries, three toolkits, one disease.
---------------------------------------------------
Script-prep: Pelin Golforoush, Tatyana Storozhenko
Interviewer: Pelin Golforoush, Tatyana Storozhenko
E36: Manuel Mayr
In this episode of AtheroTalk, we sit down with Prof. Manuel Mayr to explore how proteomics, multi-omics, and systems biology are transforming the way we understand cardiovascular disease. From decoding complex …
Notas del episodio
In this episode of AtheroTalk, we sit down with Prof. Manuel Mayr to explore how proteomics, multi-omics, and systems biology are transforming the way we understand cardiovascular disease. From decoding complex molecular networks to discussing the future of AI-driven medicine, Prof. Mayr shares a fascinating perspective on the evolving landscape of cardiovascular research and the challenges of translating massive datasets into meaningful clinical insight. Beyond the science, the conversation reflects on curiosity, mentorship, and building a career driven by genuine passion.
---------------------------------------------------
Script-prep: Pelin Golforoush
Interviewer: Pelin Golforoush
E35: Dagmar Kratky
Prof. Dagmar Kratky is often called the “queen of lipid hydrolases” — and in this episode of AtheroTalk, she shares her passion for this fascinating field. Discover how cells store and mobilize fat, why …
Notas del episodio
Prof. Dagmar Kratky is often called the “queen of lipid hydrolases” — and in this episode of AtheroTalk, she shares her passion for this fascinating field. Discover how cells store and mobilize fat, why maintaining the balance between these processes is essential for metabolic health, and which lipid hydrolases still remain to be discovered. Beyond the science, Dagmar Kratky also shares personal insights into the key milestones of her career and offers inspiring advice for young scientists: “Stay persistent, try again, never give up, and never take it personally — just try again, and it will work.” An inspiring conversation about scientific curiosity, resilience, and the future of lipid research.
---------------------------------------------------
Script-prep: Azin Kheirkhah
Interviewer: Marion Mussbacher
E34: Zanfina Ademi
What does it take to turn scientific evidence into healthcare policy that improves lives? In this AtheroTalk episode, we sit down with Prof. Zanfina Ademi, a leading health economist at Monash University, to …
Notas del episodio
What does it take to turn scientific evidence into healthcare policy that improves lives? In this AtheroTalk episode, we sit down with Prof. Zanfina Ademi, a leading health economist at Monash University, to explore how health economics shapes modern cardiovascular prevention. From the development of Productivity-Adjusted Life Years (PALYs) to the global push for lipoprotein(a) testing, Prof. Ademi shares insights from her remarkable career at the intersection of science, policy, and public health. Join us for an inspiring conversation about innovation, impact, and the future of cardiovascular care.
---------------------------------------------------
Script-prep: Azin Kheirkhah
Interviewer: Azin Kheirkhah
E33: Raul Santos
This episode of AtheroTalk features Prof. Raul Santos from Brazil, reflecting on his journey in cardiovascular medicine and his impact on the field of lipidology. The discussion covers advances in familial …
Notas del episodio
This episode of AtheroTalk features Prof. Raul Santos from Brazil, reflecting on his journey in cardiovascular medicine and his impact on the field of lipidology. The discussion covers advances in familial hypercholesterolemia, LDL lowering, and emerging therapies like Lp(a), alongside the real-world challenges of prevention across different regions. Combining scientific insight with personal perspective, it’s an engaging and thoughtful conversation with a clear message: stay curious, keep pushing forward, and “go after your dreams”.
---------------------------------------------------
Script-prep: Pelin Golforoush
Interviewer: Pelin Golforoush
E32: Pablo Corral
What does it take to build a career at the intersection of clinical care, research, and global collaboration? In this episode of AtheroTalk, we speak with Prof. Pablo Corral from Argentina, who brings a …
Notas del episodio
What does it take to build a career at the intersection of clinical care, research, and global collaboration? In this episode of AtheroTalk, we speak with Prof. Pablo Corral from Argentina, who brings a grounded and insightful perspective on lipid disorders, cardiovascular prevention, and the evolving role of large-scale clinical trials.
From tackling familial hypercholesterolemia to addressing residual risk, he shares both the realities and possibilities of advancing care in Latin America. Along the way, he reflects on mentorship, career choices, and what truly sustains long-term motivation, captured in one simple idea: “Find something you are truly passionate about.”
A thoughtful conversation for anyone navigating science, medicine, and purpose.
---------------------------------------------------
Script-prep: Pelin Golforoush
Interviewer: Pelin Golforoush
E31: Rory Collins
In this episode, Prof. Rory Collins shares the personal moments that shaped his career and pulls back the curtain on UK Biobank: how it really works, the tough calls, and the surprises along the way. As more of …
Notas del episodio
In this episode, Prof. Rory Collins shares the personal moments that shaped his career and pulls back the curtain on UK Biobank: how it really works, the tough calls, and the surprises along the way. As more of us rely on UKB for our research, this candid conversation is a must-listen for anyone using the resource: the context, trade-offs, and behind-the-scenes details you don’t usually get.
---------------------------------------------------
Script-prep: Hana Bartuskova, Azin Kheirkhah, Elena Rodriguez-Sanchez
Interviewer: Alexandr Ceasovschih, Azin Kheirkhah
E30: Magdalena Daccord
This interview features Magdalena Daccord, CEO of FH Europe Foundation, discussing key challenges and future directions in the management of familial hypercholesterolemia (FH). The conversation focuses on …
Notas del episodio
This interview features Magdalena Daccord, CEO of FH Europe Foundation, discussing key challenges and future directions in the management of familial hypercholesterolemia (FH). The conversation focuses on patient advocacy, early diagnosis, and the importance of international collaboration between clinicians, researchers, and policymakers. Special attention is given to emerging initiatives, including the Lp(a) International Task Force, and the role of patient networks in improving awareness and access to care.
---------------------------------------------------
Script-prep: Maria Cherska, Azin Kheirkhah, Svetlana Stoica
Interviewer: Maria Cherska, Svetlana Stoica
E29: John J.P. Kastelein
In this episode of AtheroTalk, we are honored to host Prof. John J.P. Kastelein, one of the most influential figures in lipidology and cardiovascular prevention. With a career spanning decades of groundbreaking …
Notas del episodio
In this episode of AtheroTalk, we are honored to host Prof. John J.P. Kastelein, one of the most influential figures in lipidology and cardiovascular prevention.
With a career spanning decades of groundbreaking research and innovation, Prof. Kastelein shares his personal journey and reflects on the evolution of lipid-lowering therapy — from the early days of statins to today’s rapidly expanding pipeline of novel therapeutics.
Together, we explore the milestones that have shaped modern cardiovascular prevention, the lessons learned along the way, and the exciting future of precision lipid management. This conversation offers unique insights into the intersection of science, clinical practice, and drug development, from someone who has been at the forefront of it all.
---------------------------------------------------
Script-prep: Fotis Barkas
Interviewer: Fotis Barkas
E28: Rodrigo Alonso Karlezi
In this special global episode of AtheroTalk, the EAS Young Fellows move beyond their traditionally Europe-focused conversations to connect with Professor Rodrigo Alonso Karlezi in Chile, bringing a Latin …
Notas del episodio
In this special global episode of AtheroTalk, the EAS Young Fellows move beyond their traditionally Europe-focused conversations to connect with Professor Rodrigo Alonso Karlezi in Chile, bringing a Latin American perspective to cardiovascular science. The discussion explores international advances in familial hypercholesterolaemia, and the power of international collaboration, while also addressing challenges faced in Latin America such as limited resources, differences in guidelines, and the need to build sustainable research networks. Reflecting on perseverance in global science, Prof. Karlezi reminds us that “no doesn’t mean ‘no’, it means ‘not yet’.”
---------------------------------------------------
Script-prep: Pelin Golforoush
Interviewer: Pelin Golforoush
E27: Gerald Watts
In this episode of AtheroTalk, we discuss with Prof. Gerald F. Watts, a leading world expert in the field of Familial Hypercholesterolemia (FH) and Cardio-metabolic Medicine, about his professional journey …
Notas del episodio
In this episode of AtheroTalk, we discuss with Prof. Gerald F. Watts, a leading world expert in the field of Familial Hypercholesterolemia (FH) and Cardio-metabolic Medicine, about his professional journey, about national strategies and policies in FH and about how can young professionals achieve a successful career.
Prof. Watts shares his insights about the process of adding clinical meaning into research projects, his mentors and overcoming challenges. He also shares ways to address gaps in care, a fresh perspective on cardiometabolic prevention, methods of thinking and ideas that help researchers keep their research relevant.
Tune in and don’t miss the powerful motto that Prof. Watts has followed throughout his exceptional career – “discovery comes to the prepared mind”.
---------------------------------------------------
Script-prep: Laura Gaita, Maria Giovanna Lupo
Interviewer: Laura Gaita
E26: Göran K. Hansson
Our guest, Prof. Göran K. Hansson, has spent a lifetime advancing cardiovascular science while helping steward one of the world’s most prestigious scientific institutions. His work as a Professor at Karolinska …
Notas del episodio
Our guest, Prof. Göran K. Hansson, has spent a lifetime advancing cardiovascular science while helping steward one of the world’s most prestigious scientific institutions. His work as a Professor at Karolinska Institutet and former Secretary General of the Royal Swedish Academy of Sciences, bridges discovery, leadership, and recognition.
He reflects on his clinical and academic journey and opens a window into his long service on the Nobel Committee for Physiology or Medicine.
---------------------------------------------------
Script-prep: Alexandr Ceasovschih, Maria Cherska
Interviewer: Alexandr Ceasovschih
E25: Ruth Frikke-Schmidt
In this episode of AtheroTalk, we talk with Prof. Ruth Frikke-Schmidt, a clinician and cardiovascular researcher, about curiosity, purpose, and growing into a life in science. She shares insights from her work …
Notas del episodio
In this episode of AtheroTalk, we talk with Prof. Ruth Frikke-Schmidt, a clinician and cardiovascular researcher, about curiosity, purpose, and growing into a life in science. She shares insights from her work on cardiovascular disease and genetics, and offers honest reflections on mentorship, setbacks, and balancing research with clinical work. It’s an inspiring listen for students and early-career researchers, ending with a piece of advice that’s both simple and powerful: “One thing at a time.”
---------------------------------------------------
Script-prep: Pelin Golforoush
Interviewer: Pelin Golforoush
E24: Frederick Raal
In this AtheroTalk episode, Prof. Frederick Raal - a distinguished Professor at the University of the Witwatersrand and one of the world’s leading experts in familial hypercholesterolemia - shares insights from …
Notas del episodio
In this AtheroTalk episode, Prof. Frederick Raal - a distinguished Professor at the University of the Witwatersrand and one of the world’s leading experts in familial hypercholesterolemia - shares insights from his clinical and research journey.
He discusses balancing clinical duties with leading one of the largest HoFH cohorts globally, highlighting the importance of mentorship, curiosity, and disciplined time management.
Prof. Raal explains the expanding role of PCSK9 and ANGPTL3 inhibitors, emphasizing combination therapy as essential for HoFH.
He reflects also on unanswered questions regarding long-term safety of PCSK9 inhibitors, the promise and challenges of gene-editing approaches, and the urgent need to improve global access to advanced lipid-lowering therapies.
---------------------------------------------------
Script-prep: Fotios Barkas
Interviewer: Fotios Barkas
E23: Ron Blankstein
In this episode of AtheroTalk, Prof. Ron Blankstein, a leading expert in cardiovascular imaging and prevention, discusses his professional journey, the power of coronary artery calcium scoring, innovations in …
Notas del episodio
In this episode of AtheroTalk, Prof. Ron Blankstein, a leading expert in cardiovascular imaging and prevention, discusses his professional journey, the power of coronary artery calcium scoring, innovations in cardiac CT, and the future of cardiovascular risk prediction.
---------------------------------------------------
Script-prep: Tatyana Storozhenko
Interviewer: Tatyana Storozhenko
E22: Rohan Khera
In this episode of the AtheroTalk, we speak with Dr Rohan Khera from the Yale School of Medicine - a leading expert in big data and artificial intelligence, and their applications in cardiovascular medicine …
Notas del episodio
In this episode of the AtheroTalk, we speak with Dr Rohan Khera from the Yale School of Medicine - a leading expert in big data and artificial intelligence, and their applications in cardiovascular medicine. Are you curious about digital phenotyping? Do you want to know which AI-powered tools are already in use or soon will be in clinical practice? Did you know that a simple ECG recording can reveal far more about the heart than just its electrophysiological properties?
---------------------------------------------------
Script-prep: Azin Kheirkhah, Jan Novák
Interviewer: Jan Novák
E21: 2025 Focused Update of the 2019 ESC/EAS Guidelines for the management of dyslipidaemias
This episode explores the 2025 Focused Update of the 2019 ESC/EAS Guidelines for the Management of Dyslipidaemias, highlighting key changes in cardiovascular risk assessment, LDL-C targets, Lp(a) …
Notas del episodio
This episode explores the 2025 Focused Update of the 2019 ESC/EAS Guidelines for the Management of Dyslipidaemias, highlighting key changes in cardiovascular risk assessment, LDL-C targets, Lp(a) interpretation, and lipid-lowering strategies. Listeners gain practical insights into how these updates impact everyday clinical decision-making and the future of dyslipidaemia management.
-------------------------------------------------
Script-prep: Fotios Barkas, Maria Cherska
Interviewer: Fotios Barkas, Maria Cherska
E20: Bart van de Sluis
We sit down with Prof. Bart van de Sluis, Professor of Molecular Genetics and Translational Biology at the University of Groningen (UMCG). His research unravels the molecular mechanisms that control lipid …
Notas del episodio
We sit down with Prof. Bart van de Sluis, Professor of Molecular Genetics and Translational Biology at the University of Groningen (UMCG). His research unravels the molecular mechanisms that control lipid metabolism and endo-lysosomal cholesterol transport, key processes in cardiometabolic diseases such as fatty liver disease and atherosclerosis.
Prof. van de Sluis leads a research group dedicated to understanding how receptor trafficking and inflammation are regulated, with a focus on the NF-κB signaling pathway. Using advanced cellular and mouse models, including CRISPR/Cas approaches, his team pushes the boundaries of molecular medicine. Beyond his research, he heads the Transgenic Mouse Clinic for Aging Research (CRISPR facility).
Join us as we talk about his scientific journey, the challenges of translational research, and his vision for the future of molecular biology and cardiovascular science.
-------------------------------------------------
Script-prep: Hana Bartuskova, Maria Giovanna Lupo, Sanne Maas, Tatyana Storozhenko
Interviewer: Sanne Maas
E19: Michael Shapiro
This time, we interview Prof. Michael Shapiro, President of the American Association of Preventive Cardiology and Chair-Elect of the AHA Council on Lipidology, Lipoprotein, Metabolism & Thrombosis. We delve …
Notas del episodio
This time, we interview Prof. Michael Shapiro, President of the American Association of Preventive Cardiology and Chair-Elect of the AHA Council on Lipidology, Lipoprotein, Metabolism & Thrombosis. We delve into his academic journey and explore his predictions for the future of our field.
---------------------------------------------------
Script-prep: Azin Kheirkhah, Svetlana Stoica, Tatyana Storozhenko
Interviewer: Svetlana Stoica
E18: EAS Paediatric Lipid Working Group
Tune in to this special FH Awareness Week episode of our podcast featuring Prof. Steve Humphries. In this conversation, he shares valuable insights into familial hypercholesterolaemia (FH) and introduces the …
Notas del episodio
Tune in to this special FH Awareness Week episode of our podcast featuring Prof. Steve Humphries. In this conversation, he shares valuable insights into familial hypercholesterolaemia (FH) and introduces the newly established EAS Paediatric Lipid Working Group. He highlights the importance of early detection, collaboration, and awareness to improve care and outcomes for children living with inherited lipid disorders.
---------------------------------------------------
Script-prep: Hana Bartuskova, Joana Rita Chora, Laura Gaita, Azin Kheirkhah
Interviewer: Azin Kheirkhah
E17: EAS Consensus Statement on Systemic Metabolic Disorders
Rates of obesity and related metabolic disorders have risen dramatically worldwide, yet most treatment strategies still focus on individual conditions, missing the bigger picture. A new Consensus Statement from …
Notas del episodio
Rates of obesity and related metabolic disorders have risen dramatically worldwide, yet most treatment strategies still focus on individual conditions, missing the bigger picture. A new Consensus Statement from the European Atherosclerosis Society introduces a holistic, clinically actionable framework that reflects disease progression across three stages, from early metabolic changes to advanced organ damage.
In this episode, we discuss this new staging system in detail in an interview with the lead author, and we also hear from two EAS Young Fellows who worked behind the scenes, offering unique insights that go beyond what is published in the manuscript.
---------------------------------------------------
Script-prep: Mariia Cherska, Azin Kheirkhah, Elena Rodriguez Sanchez
Interviewer: Azin Kheirkhah, Elena Rodriguez Sanchez
E16: Simon Pfisterer
In this episode, our guest is Dr Simon Pfisterer, group leader at the University of Helsinki and Chief Scientific Officer of Moncyte Ltd. His work bridges cutting-edge research and clinical application in …
Notas del episodio
In this episode, our guest is Dr Simon Pfisterer, group leader at the University of Helsinki and Chief Scientific Officer of Moncyte Ltd. His work bridges cutting-edge research and clinical application in dyslipidaemia and cardiovascular disease. We're talking about his academic journey, his move into biotech, and his vision for the future of precision medicine in atherosclerosis.
---------------------------------------------------
Script-prep: Joana Chora, Sanne Maas, Elena Rodriguez Sanchez
Interviewer: Sanne MaasE15: Gemma Figtree
In this episode, a leading interventional cardiologist and pioneering researcher, Prof. Gemma Figtree brings a unique perspective at the intersection of clinical care, molecular science, and national health …
Notas del episodio
In this episode, a leading interventional cardiologist and pioneering researcher, Prof. Gemma Figtree brings a unique perspective at the intersection of clinical care, molecular science, and national health strategy. From her early academic journey to groundbreaking work, Prof. Figtree shares ideas that are as inspiring as they are impactful. Join us for a conversation that explores not only the science but also the passion, resilience, and vision at the frontlines of cardiology.
---------------------------------------------------
Script-prep: Elena Rodriguez Sanchez, Tatyana Storozhenko
Interviewer: Tatyana Storozhenko
E14: Judith Sluimer & Keith Channon
In this special AtheroTalk live episode from the EAS Congress floor, hosts Emiel van der Vorst and Azin Kheirkhah sit down with two leading experts and successful grant winners in cardiovascular research—Prof …
Notas del episodio
In this special AtheroTalk live episode from the EAS Congress floor, hosts Emiel van der Vorst and Azin Kheirkhah sit down with two leading experts and successful grant winners in cardiovascular research—Prof. Judith Sluimer, recipient of the prestigious Vici grant from the Dutch Research Council (NWO), and Prof. Keith Channon, honored with the British Heart Foundation (BHF) Research Excellence Award.
Together, they offer a candid look at what it really takes to secure major research funding. From early grant attempts and tough rejections to imposter syndrome and practical proposal strategies, this 20-minute conversation (plus live audience Q&A) delivers rare behind-the-scenes insights and advice for aspiring grant applicants.
E13: Noam Zelcer
In this episode, we talk with Prof. Noam Zelcer, a globally respected expert in the field of molecular regulation of lipid metabolism and cardiometabolic diseases. He shares his perspectives on the evolving …
Notas del episodio
In this episode, we talk with Prof. Noam Zelcer, a globally respected expert in the field of molecular regulation of lipid metabolism and cardiometabolic diseases. He shares his perspectives on the evolving field of lipid metabolism research. Besides his scientific insights, he encourages us to discuss our failures, which are “a feature of science, not a bug”. Another key message: “Define clear go/no-go milestones for your project”.
If you are interested in his work, he currently has an open position for a PhD student as also discussed during this episode.
-------------------------
Script-prep: Pelin Golforoush, Emiel van der Vorst
Interviewer: Emiel van der Vorst
Aquí están los 40 episodios más recientes de 42. Los anteriores están en el feed del podcast.
Podcasts similares
Más podcasts de Salud y forma física
¿Es tu podcast?
Confírmalo con una entrada en tu feed: aquí recibes un código, lo añades como podcast:txt en el canal de tu feed y nosotros lo comprobamos. Después tu podcast aparecerá como «verificado» en SoundNode.